1. Department of Investigational Cancer Therapeutics The University of Texas MD Anderson Cancer Center Houston Texas USA
2. Department of Internal Medicine Seoul National University Hospital, and Cancer Research Institute, Seoul National University College of Medicine Seoul Republic of Korea
3. Department of Gastroenterology Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center Yokohama Japan
4. Département de Médecine Oncologique Gustave Roussy, Université Paris‐Saclay Villejuif France
5. Department of Medical Oncology, Yonsei Cancer Center Yonsei University College of Medicine Seoul Republic of Korea
6. Blacktown Cancer and Haematology Centre Blacktown Hospital and University of Sydney Sydney New South Wales Australia
7. Division of Hematology/Oncology University of California San Francisco San Francisco California USA
8. Division of Pharmacology Antoni van Leeuwenhoek Ziekenhuis Amsterdam Netherlands
9. Early phase Trials and Sarcoma Units Institut Bergonié Bordeaux France
10. Department of Medical Oncology Kindai University Hospital Osaka Japan
11. Helen Diller Family Comprehensive Cancer Center University of California San Francisco San Francisco California USA
12. Department of Oncology and Hemato‐Oncology University of Milan and Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale Tumori Milan Italy
13. Department of Drug Development Gustave Roussy, Université Paris‐Saclay Villejuif France
14. Division of Medical Oncology Princess Margaret Cancer Centre Toronto Ontario Canada
15. Biostatistical and Research Decision Sciences, Merck & Co., Inc. Kenilworth New Jersey USA
16. Oncology Late Development, Merck & Co., Inc. Kenilworth New Jersey USA
17. Department of Experimental Therapeutics/Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan